Sciclone Pharma (SCLN) Reports Q2 EPS of $0.20
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
Sciclone Pharma (NASDAQ: SCLN) reported Q2 EPS of $0.20, versus $0.26 reported last year. Revenue for the quarter came in at $39 million, versus $37.9 million reported last year.
Outlook for 2016
SciClone projects its 2016 revenue to be in the range of $158 million to $163 million and expects that non-GAAP earnings per share on a fully diluted basis to be in the range of $0.70 to $0.74 for the year.
For earnings history and earnings-related data on Sciclone Pharma (SCLN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: Corelogic (CLGX) Tops Q3 EPS by 7c, Expects to Achieve Upper Ends of FY16 Guidance
- Swift Transportation (SWFT) Tops Q3 EPS by 2c; Reaffirms
- Buckeye Partners (BPL) Tops Q3 EPS by 22c
Create E-mail Alert Related CategoriesEarnings, Guidance
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!